» Authors » Stamatios Gregoriou

Stamatios Gregoriou

Explore the profile of Stamatios Gregoriou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 219
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Apostolos A, Gregoriou S, Drakopoulou M, Trantalis G, Tsiogka A, Ktenopoulos N, et al.
Circ Cardiovasc Interv . 2025 Mar; PMID: 40057986
Nickel-containing devices, such as the Amplatzer PFO Occluder and Gore® Cardioform Septal Occluder (GSO), are used for transcatheter patent foramen ovale (PFO) closure. However, the impact of nickel hypersensitivity on...
2.
Gregoriou S, Tsiogka A, Stratigos A, Agiasofitou E
Dermatol Surg . 2025 Mar; PMID: 40035721
No abstract available.
3.
Koumaki D, Koumaki V, Gregoriou S, Evangelou G, Rovithi E, Petrou D, et al.
Int J Dermatol . 2025 Mar; PMID: 40022487
No abstract available.
4.
Koumaki D, Maraki S, Evangelou G, Koumaki V, Gregoriou S, Kouloumvakou S, et al.
J Clin Med . 2025 Feb; 14(4). PMID: 40004615
Methicillin-resistant (MRSA) poses significant treatment challenges, particularly in community settings. Limited data are available on -associated infected dermatoses (ID) in outpatient dermatology clinics. This study examines the clinical characteristics, microbiological...
5.
Koumprentziotis I, Tsiogka A, Rompoti N, Soulaidopoulos S, Nikolaou V, Gregoriou S, et al.
J Eur Acad Dermatol Venereol . 2025 Feb; PMID: 39985226
No abstract available.
6.
Gregoriou S, Koumprentziotis I, Kleidona I, Bakakis M, Hatzidimitriou E, Douvali T, et al.
Arch Dermatol Res . 2025 Feb; 317(1):387. PMID: 39937264
No abstract available.
7.
Gregoriou S, Routsi E, Koumprentziotis I, Papapanou M, Stratigos A
J Eur Acad Dermatol Venereol . 2025 Feb; PMID: 39902922
No abstract available.
8.
Gregoriou S, Koumprentziotis I, Kleidona I, Bakakis M, Hatzidimitriou E, Douvali T, et al.
Dermatol Ther (Heidelb) . 2025 Jan; 15(1):227-235. PMID: 39812942
Introduction: Results from randomized controlled trials of upadacitinib, a Janus kinase (JAK) inhibitor, have led to its approval for the treatment of moderate-to-severe atopic dermatitis (AD) in patients aged ≥ ...
9.
Koumaki D, Evangelou G, Gregoriou S, Kouloumvakou S, Manios A, Katoulis A, et al.
Cancers (Basel) . 2025 Jan; 16(24. PMID: 39766125
Backgorund: This study aimed to explore the relationship between different types of skin cancer and factors such as sun exposure and photoprotection measures in a Greek cohort on the island...
10.
Koumaki D, Gregoriou S, Evangelou G, Rovithi E, Koumaki V, Petrou D, et al.
Int J Dermatol . 2024 Dec; 64(3):571-574. PMID: 39654389
No abstract available.